2,2-BIS(DIFLUOROMETHYL)-3,4-DIHYDRO-6-NITRO-4-(1-OXIDO-2-PYRIDINYL)-2H-1,4-BENZOXAZINE
UNII XBK845EP4G
Substance Identification & Data
This profile provides standardized clinical and technical data for 2,2-bis(difluoromethyl)-3,4-dihydro-6-nitro-4-(1-oxido-2-pyridinyl)-2h-1,4-benzoxazine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XBK845EP4G.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 161229-62-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C15H11F4N3O4 LIKAVDUPUINJPY-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2,2-bis(difluoromethyl)-3,4-dihydro-6-nitro-4-(1-oxido-2-pyridinyl)-2h-1,4-benzoxazine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.